並列タイトル等食道扁平上皮癌におけるCD40の発現は腫瘍の進行とリンパ節転移に関係する
一般注記Citation: YOSHIYUKI MATSUMURA, KEI HIRAOKA, KEIDAI ISHIKAWA, YASUHITO SHOJI, TAKEHIRO NOJI, KOJI HONTANI, TOMOO ITOH, TORU NAKAMURA, TAKAHIRO TSUCHIKAWA, TOSHIAKI SHICHINOHE and SATOSHI HIRANO. CD40 Expression in Human Esophageal Squamous Cell Carcinoma Is Associated with Tumor Progression and Lymph Node Metastasis. ANTICANCER RESEARCH 36(9): 4467-4475 (2016). doi:10.21873/anticanres.10991
配架番号:2272
Background: The co-stimulatory molecule cluster of differentiation 40 (CD40) is widely expressed in various types of malignant tumors, but its role remains unclear. The purpose of this study was to investigate the relationship between CD40 expression and clinicopathological variables in patients with esophageal squamous cell carcinoma (ESCC), as well as the function of CD40 expressed on ESCC tumor cells in vitro. Materials and Methods: Tumor specimens of patients who underwent surgical resection for ESCC were immunohistochemically analyzed for CD40 expression. Results: Of the 122 specimens, 45 (37%) were positive for CD40. Significant positive correlation was found between CD40 expression and p-stage (p=0.0011), histopathological grade (p=0.0143), pT-classification (p=0.0011), and pN-classification (p=0.0007). Survival of patients with stage III and IV disease with positive CD40 expression was significantly shorter than that of those with negative expression (log-rank test, p=0.0422). In in vitro analysis, while the addition of recombinant human CD154 did not inhibit growth, it did induce a significant increase in interleukin 6 production in ESCC cell lines. Conclusion: These results suggest that functional expression of CD40 on tumor cells might play an important role in tumor progression and lymph node metastasis in ESCC.
(主査) 教授 秋田 弘俊, 准教授 本間 明宏, 教授 平野 聡
医学研究科(癌医学専攻)
コレクション(個別)国立国会図書館デジタルコレクション > デジタル化資料 > 博士論文
受理日(W3CDTF)2017-08-02T04:31:34+09:00
連携機関・データベース国立国会図書館 : 国立国会図書館デジタルコレクション